Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia
Gemma Navarro, Dasiel O. Borroto‐Escuela, Edgar Angelats, et al.
Brain Behavior and Immunity (2017) Vol. 67, pp. 139-151
Closed Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
Piyoosh Sharma, Pavan Srivastava, Ankit Seth, et al.
Progress in Neurobiology (2018) Vol. 174, pp. 53-89
Closed Access | Times Cited: 285
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Nour M. Moussa‐Pacha, Shifaa M. Abdin, Hany A. Omar, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 1, pp. 339-384
Open Access | Times Cited: 246
Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104961-104961
Closed Access | Times Cited: 83
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes
Gemma Navarro, Katia Varani, Irene Reyes‐Resina, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 118
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Caiyun Liu, Xu Wang, Chang Liu, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 114
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
Gemma Navarro, Katia Varani, Alejandro Lillo, et al.
Pharmacological Research (2020) Vol. 159, pp. 104940-104940
Open Access | Times Cited: 77
The cannabinoid system and microglia in health and disease
Samuel S. Duffy, Jessica P. Hayes, Nathan T. Fiore, et al.
Neuropharmacology (2021) Vol. 190, pp. 108555-108555
Closed Access | Times Cited: 71
The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation
A. P. Young, Eileen M. Denovan‐Wright
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 55
Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes
Gemma Navarro, Irene Reyes‐Resina, Rafael Rivas‐Santisteban, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 148-158
Closed Access | Times Cited: 82
Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases
Irene Reyes‐Resina, Gemma Navarro, David Aguinaga, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 169-179
Open Access | Times Cited: 65
Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke
Iu Raïch, Jaume Lillo, Rafael Rivas‐Santisteban, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6708-6708
Open Access | Times Cited: 6
Emerging Role of (Endo)Cannabinoids in Migraine
Pinja Leimuranta, Leonard Khiroug, Rashid Giniatullin
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 54
Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation
Dasiel O. Borroto‐Escuela, Sonja Hinz, Gemma Navarro, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 50
Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists
Rafael Franco, Irene Reyes‐Resina, David Aguinaga, et al.
Glia (2019) Vol. 67, Iss. 12, pp. 2410-2423
Closed Access | Times Cited: 47
Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
Mohammad Zakir Hossain, Hiroshi Ando, Shumpei Unno, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1423-1423
Open Access | Times Cited: 47
Adenosine A2A Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer’s Disease
Rafael Franco, Rafael Rivas‐Santisteban, M Casanovas, et al.
Cells (2020) Vol. 9, Iss. 5, pp. 1075-1075
Open Access | Times Cited: 45
Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer’s, Parkinson’s, and Huntington’s Diseases
Catalina Pérez-Olives, Rafael Rivas‐Santisteban, Jaume Lillo, et al.
Advances in experimental medicine and biology (2020), pp. 81-92
Closed Access | Times Cited: 43
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Rafael Franco, Rafael Rivas‐Santisteban, Irene Reyes‐Resina, et al.
Pharmacological Research (2020) Vol. 158, pp. 104801-104801
Closed Access | Times Cited: 40
Endocannabinoid signaling in microglia
Sara Marinelli, Maria Cristina Marrone, Marina Di Domenico, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 71-90
Closed Access | Times Cited: 26
Synthetic cannabinoids reduce the inflammatory activity of microglia and subsequently improve neuronal survival in vitro
A. P. Young, Eileen M. Denovan‐Wright
Brain Behavior and Immunity (2022) Vol. 105, pp. 29-43
Closed Access | Times Cited: 23
Research progress on the cannabinoid type-2 receptor and Parkinson’s disease
Xiao‐Qi Yu, Yi Jia, Yuan Dong
Frontiers in Aging Neuroscience (2024) Vol. 15
Open Access | Times Cited: 5
Cellular and Molecular Effects of Microgravity on the Immune System: A Focus on Bioactive Lipids
Marina Fava, Noemi De Dominicis, Giulia Forte, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 446-446
Open Access | Times Cited: 5
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
Andrea Manterola, Ana Bernal‐Chico, Raffaela Cipriani, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 189-201
Open Access | Times Cited: 42
Biased receptor functionality versus biased agonism in G-protein-coupled receptors
Rafael Franco, David Aguinaga, Jasmina Jiménez, et al.
BioMolecular Concepts (2018) Vol. 9, Iss. 1, pp. 143-154
Open Access | Times Cited: 40
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
Rui S. Rodrigues, Diogo M. Lourenço, Sara L. Paulo, et al.
Molecules (2019) Vol. 24, Iss. 7, pp. 1350-1350
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top